Azienda Ospedaliera Universitaria Policlinico Tor Vergata

Torre, Roma 00133

0 studies enrolling now · 2 studies all time

What they study most

Ulcerative Colitis

Studies at this site

• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed